Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Promising Class of New Cancer Drugs Cause Memory Loss in Mice

August 25, 2015 7:45 am | by Rockefeller University | News | Comments

These therapies act on a group of proteins that help regulate the expression of many genes, some of which play a role in cancer. Read more...

TOPICS:

Sierra Leone Releases Its Last Known Ebola Patient

August 25, 2015 7:30 am | by Clarence Roy-Macaulay, Associated Press | News | Comments

Health authorities in Sierra Leone released the country's last known Ebola patient from the hospital on Monday. Read more...

TOPICS:

Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies

August 24, 2015 11:39 am | by Children's Hospital of Philadelphia | News | Comments

Scientists who analyzed the genes involved in 10 autoimmune diseases that begin in childhood have discovered 22 genome-wide signals shared by two or more diseases. These shared gene sites may reveal potential new targets for treating many of these diseases, in some cases with existing drugs already available for non-autoimmune disorders. Read more...

TOPICS:
Advertisement

New Study Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine

August 24, 2015 11:06 am | by The Scripps Research Institute | News | Comments

Scientists from The Scripps Research Institute (TSRI) and the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots. Read more...

TOPICS:

Scientists Uncover Surprising Mechanism Behind Antibiotic-Resistant Bacteria

August 24, 2015 10:35 am | by The Scripps Research Institute | News | Comments

Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too. Read more...

TOPICS:

Second Cancers Are on the Rise; 1 In 5 U.S. Cases Is a Repeat

August 24, 2015 10:08 am | by Marilynn Marchione, AP Medical Writer | News | Comments

Second cancers are on the rise. Nearly 1 in 5 new cases in the U.S. now involves someone who has had the disease before. Read more...

TOPICS:

Powdered Cranberry Combats Colon Cancer in Mice

August 24, 2015 9:58 am | by American Chemical Society | News | Comments

Cranberries are often touted as a way to protect against urinary tract infections, but that may be just the beginning. Researchers fed cranberry extracts to mice with colon cancer and found that the tumors diminished in size and number. Read more...

TOPICS:

A Bridge for Promising Research

August 24, 2015 9:32 am | by Harvard University | News | Comments

A dozen accelerator grants help cover biomedical development gap. Read more...

TOPICS:
Advertisement

Researchers Set to Develop New Diabetes Treatment

August 24, 2015 8:49 am | by University of Otago | News | Comments

The team will use their Proof of Concept Grant to progress their product to commercialization. Read more...

TOPICS:

With Many Ebola Survivors Ailing, Doctors Evaluate Situation

August 24, 2015 8:40 am | by Carley Petesch, Associated Press | News | Comments

Lingering health problems afflicting many of the roughly 13,000 Ebola survivors have galvanized global and local health officials to find out how widespread the ailments are, and how to remedy them. Read more...

TOPICS:

Novartis to Spend $1B on Rights to GSK's MS Drug

August 24, 2015 8:30 am | by Ryan Bushey, Associate Editor | News | Comments

Novartis initially acquired the rights to the drug earlier this year for treating cancer. Read more...

TOPICS:

EMA Accepts Takeda's Marketing Authorization Application for Ixazomib

August 24, 2015 8:00 am | News | Comments

Additional filings in other countries are planned to begin later this fiscal year. Read more...

TOPICS:

Imperfect Test Fuels Alternative Treatments for Lyme Disease

August 24, 2015 7:45 am | by Matthew Perrone, AP Health Writer | News | Comments

Lyme disease conjures memories of checking for ticks at camp and fretting over bug bites after hikes in the woods. Read more...

TOPICS:

Surge in Flu This Winter

August 24, 2015 7:30 am | by University of Sydney | News | Comments

Figures from NSW Health indicate the number of outbreaks that have involved "type B" influenza are far higher than last year. Read more...

TOPICS:

Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of Trumenba

August 21, 2015 12:09 pm | News | Comments

Pfizer Inc. announced today positive topline results of two Phase 3 studies of Trumenba (Meningococcal Group B Vaccine). One study included approximately 3,600 healthy individuals 10 through 18 years of age, and the other study included approximately 3,300 healthy individuals 18 through 25 years of age. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading